Washington Capital Management Inc Halozyme Therapeutics, Inc. Put Options Transaction History

Washington Capital Management Inc

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 Apr 17, 2023	BUY	$32.86 - $55.7 $98,580 - $167,100	3,000 Added 24.0%	15,500 $591,000
Q2 2022 Jul 15, 2022	SELL	$37.35 - $48.3 $194,220 - $251,159	-5,200 Reduced 29.38%	12,500 $550,000
Q1 2022 Apr 22, 2022	BUY	$31.97 - $41.06 $35,167 - $45,166	1,100 Added 6.63%	17,700 $706,000
Q4 2021 Jan 18, 2022	BUY	$31.82 - $40.75 $528,212 - $676,450	16,600 New	16,600 $667,000

544

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.71B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Washington Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Washington Capital Management Inc with notifications on news.